A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity. By measuring RNA and proteins simultaneously, it reveals cytokine activity with greater accuracy, strengthening the foundation for understanding cancer, inflammation and treatment resistance. Published in Scientific Reports, the findings could ultimately sharpen immunotherapy design and improve predictions of patient response.
This article was originally published on MedicalXpress.com
